HKU Scholars Hub: Browsing DSpace

Browsing by Author Yuen, JCH

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 36 to 55 of 75 < previous next >

Title	Author(s)	Issue Date	Views
A large population histology study showing the lack of association between ALT elevation and significant fibrosis in chronic hepatitis B Journal:PLoS ONE	Seto, WK Lai, CL Ip, PPC Fung, J Wong, DKH Yuen, JCH Hung, IFN Yuen, MF	2012	202
Large population study in liver stiffness measurement: prevalence of significant fibrosis and correlation with Liver Biochemistry in Chronic Hepatitis B Proceeding/Conference:Journal of Hepatology	Fung, JYY Lai, CL Yuen, JCH Wong, DKH Cheng, CTK But, DY Yuen, RMF	2007	117
Large scale longitudinal study of chronic hepatitis B patients with hepatitis B surface antigen seroclearance Proceeding/Conference:Journal of Hepatology	Wong, DKH Lai, CL Fung, JYY But, D Hung, IFN Yuen, JCH Fung, FKC Young, JLP Yuen, RMF	2007	111
Liver histology of Asian patients with chronic hepatitis B on prolonged lamivudine therapy Journal:Alimentary Pharmacology and Therapeutics	Yuen, MF Chow, DHF Tsui, K Wong, BCY Yuen, JCH Wong, DKH Lai, CL	2005
Long-term lamivudine therapy reduces the risk of long-term complications of chronic hepatitis B infection even in patients without advanced disease Journal:Antiviral Therapy	Yuen, MF Seto, WK Chow, DHF Tsui, K Wong, DKH Ngai, VWS Wong, BCY Fung, J Yuen, JCH Lai, CL	2007	138
Longitudinal study of hepatitis activity and viral replication before and after HBeAg seroconversion in chronic hepatitis B patients infected with genotypes B and C Journal:Journal of Clinical Microbiology	Yuen, MF Fung, SK Tanaka, Y Kato, T Mizokami, M Yuen, JCH Wong, DKH Yuan, HJ Sum, SM Chan, AOO Wong, BCY Lai, CL	2004	140
Low serum HBV DNA levels and development of hepatocellular carcinoma in patients with chronic hepatitis B: A case-control study Journal:Alimentary Pharmacology and Therapeutics	Fung, J Yuen, MF Yuen, JCH Wong, DKH Lai, CL	2007	171
Outcome of lamivudine-resistant chronic hepatitis B after up to 5 years of combination therapy with adefovir Journal:Antiviral Therapy	Seto, WK Liu, K Fung, J Wong, DKH Yuen, JCH Hung, IFN Lai, CL Yuen, MF	2012	101
Phase I/II double-blind, randomized, placebo-controlled study of the novel anti-HBV agent LB80380/ANA380 in patients with chronic HBV infection Proceeding/Conference:Hepatology	Yuen, RMF Kim, J Averett, D Wong, DKH Kim, CR Kerr, B Ngai, WS Yuen, JCH Lai, CL	2004	143
A phase I/IIa, double-blind, randomized, placebo-controlled trial of a novel antiviral agent, LB80380 in patients with chronic hepatitis B infection Proceeding/Conference:Antiviral Research	Yuen, RMF Kim, J Wong, DKH Ngai, WS Yuen, JCH Lai, CL	2003	61
Pin1 over-expression and β-catenin gene mutations are distinct oncogenic events in human hepatocarcinogenesis. Proceeding/Conference:Hong Kong International Cancer Congress, HKICC 2003	Pang, RWC Yuen, JCH Yuen, RMF Lai, CL Kwong, YL Tse, EWC	2003	93
Predictive model for fibrosis and cirrhosis in chronic hepatitis B using liver stiffness measurement Proceeding/Conference:Hepatology	Fung, JYY Lai, CL Fong, DYT Yuen, JCH Wong, DKH Yuen, RMF	2007	115
Predictive value of HBV DNA levels at frequent time points during early and maintenance phase of 5-year laminudine and mutational profiles of reverse transcriptase (RT) and surface (S) genes Proceeding/Conference:Hepatology	Yuen, RMF Wong, DKH Fung, JYY Yuen, JCH Lai, CL	2006	148
Prevalence and significance of hepatitis GB virus-C/hepatitis G virus viremia in a large cohort of patients with chronic hepatitis B infection, with chronic hepatitis C infection, and on renal replacement therapy in Hong Kong Journal:Digestive Diseases and Sciences	Yuen, MF Chan, TM Terence PokSiu, YIP Yuen, JCH Ho, SKN Lai, CL	2002	129
Prevalence of occult hepatitis B infection in a highly endemic area for chronic hepatitis B: A study of a large blood donor population Journal:Gut	Yuen, MF Lee, CK Wong, DKH Fung, J Hung, I Hsu, A But, DYK Cheung, TK Chan, P Yuen, JCH Fung, FKC Seto, WK Lin, CK Lai, CL	2010	166
Profiles of HBV DNA, ALT, and HBeAg status after stopping lamivudine in patients with HBeAg seroconversion Proceeding/Conference:Hepatology	Fung, JYY Lai, CL Tanaka, Y Mizokami, M Yuen, JCH Wong, DKH Yuen, RMF	2007	89
Profound reduction of HBV covalently closed circular DNA with long-term nucleoside/tide analogue therapy Proceeding/Conference:Hepatology	Lai, CL Wong, DKH Ip, P Kopaniszen, M Seto, WK Fung, J Huang, FY Lee, BP Cullaro, G Wu, CH Cheng, C Yuen, JCH Ngai, V Yuen, MF	2014	124
Prognostic determinants for chronic hepatitis B in Asians: Therapeutic implications Journal:Gut	Yuen, MF Yuan, HJ Wong, DKH Yuen, JCH Wong, WM Chan, AOO Wong, BCY Lai, KC Lai, CL	2005	153
Quantification of hepatitis B virus covalently closed circular DNA in patients with hepatocellular carcinoma Journal:Journal of Hepatology	Wong, DKH Yuen, MF Poon, RTP Yuen, JCH Fung, J Lai, CL	2006	189
A randomized placebo-controlled, dose-finding study of oral LB80380 in HBeAg-positive patients with chronic hepatitis B Journal:Antiviral Therapy	Yuen, MF Kim, J Kim, CR Ngai, V Yuen, JCH Min, C Kang, HM Shin, BS Yoo, SD Lai, CL	2006

Showing results 36 to 55 of 75 < previous next >